Complete Genomics Inc (GNOM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Complete Genomics Inc (Complete Genomics) is a biotechnology company which provides human genome sequencing and analysis services. The company offers sequencing technology, process automation technology and data management solution. It has sequenced more than 20,000 whole human genomes using sequencing instruments, chemistry and software. Complete Genomics components of sequencing technology include DNA nanoball arrays and combinatorial probe-anchor ligation reads. The companys human genome sequencing technology consists of proprietary sequencing technology, complete data management solution and DNB Nanoball Arrays. It develops technology and commercial systems to sequence and interpret human genomes for researchers and clinicians. Complete Genomics is headquartered in Mountain view, California, the US.
Complete Genomics Inc (GNOM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Complete Genomics Inc (Complete Genomics) is a biotechnology company which provides human genome sequencing and analysis services. The company offers sequencing technology, process automation technology and data management solution. It has sequenced more than 20,000 whole human genomes using sequencing instruments, chemistry and software. Complete Genomics components of sequencing technology include DNA nanoball arrays and combinatorial probe-anchor ligation reads. The companys human genome sequencing technology consists of proprietary sequencing technology, complete data management solution and DNB Nanoball Arrays. It develops technology and commercial systems to sequence and interpret human genomes for researchers and clinicians. Complete Genomics is headquartered in Mountain view, California, the US.
Complete Genomics Inc (GNOM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Complete Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Complete Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 8
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Complete Genomics Enters Into Co-Marketing Agreement With DNAnexus 10
Equity Offering 11
Complete Genomics Spin-Off Genos Research 11
Complete Genomics Announces Public Offering Of Shares For US$30 Million 11
Complete Genomics Completes An Underwritten Public Offering For US$79.1 Million 12
Acquisition 14
BGI Shenzhen Completes Acquisition Of Complete Genomics For US$118 Million 14
Complete Genomics Inc - Key Competitors 17
Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19
List Of Tables
Complete Genomics Inc, Pharmaceuticals & Healthcare, Key Facts, 2011 1
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 1
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Complete Genomics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Complete Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 8
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Complete Genomics Enters Into Co-Marketing Agreement With DNAnexus 10
Complete Genomics Spin-Off Genos Research 11
Complete Genomics Announces Public Offering Of Shares For US$30 Million 11
Complete Genomics Completes An Underwritten Public Offering For US$79.1 Million 12
BGI Shenzhen Completes Acquisition Of Complete Genomics For US$118 Million 14
Complete Genomics Inc, Key Competitors 17
List Of Figures
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Complete Genomics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Complete Genomics Inc, Medical Devices Deals, 2011 to YTD 2017 8
RELATED REPORTS
Global Hearing Aid Market: World Market Review and Analysis By Technology (Analog, Digital), Product Type, Type of Hearing Loss, End-User, Sales Channel (2019 Edition): Opportunities and Forecast (2014-2024) -- By Product Type (Behind the Ear, In the Ear, Receiver in the Ear, In the Canal, Completely in the Canal, Others), By Hearing Loss (Conductive, Sensorineural), By Distribution Channel (Independent Sellers, Retailers, Wholesale, E- Commerce, Hospital Pharmacy, Others), By End User (Pediatric, Adult)
Executive A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Hearing Aid
USD 2400 View ReportAccugenomics Inc - Product Pipeline Analysis, 2020 Update
Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including
USD 750 View ReportAutoGenomics Inc - Product Pipeline Analysis, 2020 Update
AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti
USD 750 View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS